drugset / Trial / NCT01653119
Peking and Rotterdam on Mission to Reduce Coronary Artery Disease
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to explore the effect of 20mg high loading dose of rosuvastatin on recurrent events in patients with established DM who is admitted for an ACS.
Timeline
- Start
- 2012-04
- Primary completion
- 2015-06
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rosuvastatin | Small molecule | 10 mg | — |
| Comparator | Rosuvastatin | Small molecule | 20 mg | — |